Clover Corporation Limited (ASX: CLV) - ETF Exposure

Current share price for CLV : $1.080 0.1 (10.20%)⁺

Clover Corporation Limited (CLV) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It develop and produce encapsulated bioactive ingredients, specialising in nutritional oils for infant formula, medical foods, and functional foods. The Company deliver nutritional solutions that enhance product stability, bioavailability, and health benefits.

CLV General Information ⁺

ASX Code	CLV
Website	http://www.clovercorp.com.au
Industry/Sector	Specialty Chemicals
Market Cap ($M)	180
CLV Share Price	$1.080
Day High	$1.080
Day Low	$0.990
Last Close	$0.980
CLV Share Price Movement	$0.10 ( 10.20% )

Prices as at 16:40, 25 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to CLV

Clover Corporation Limited (CLV) is held across 3 ETFs spanning strategies that include specialty chemicals exposure . Its weighting in those funds means performance can have an outsized influence - when CLV moves, funds like DACE and DAVA that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to CLV , while the average exposure across all 3 ETFs that hold it is around 0% .

Top ETF holdings

Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%
Dimensional Australian Value Trust - Active ETF (DAVA) ~ 0%

Last updated: ETF data and holdings as at 22 September 2026

Own CLV directly or through an ETF?

How does holding Clover Corporation Limited (CLV) shares directly compare to ETFs that include it?

	CLV Direct	DACE ASX	DAVA ASX
Holdings	1 company	485 holdings	167 holdings
CLV Weight	100%	0%	0%
Diversification	Single Stock	Broad	Broad
Annual Cost	Brokerage only	0.28% p.a.	0.34% p.a.
Approx. Yield	2.3%	3.05%	6.6%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not CLV's direct yield. Annual cost uses each ETF's MER.

CLV Exposure on $10,000 investment

How a $10,000 investment in Clover Corporation Limited (CLV) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Clover Corporation Limited (CLV)	Direct share	$1.080	28.57%	+$2,857	$12,857
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$18.740	-0.85%	-$85	$9,915
Dimensional Australian Value Trust - Active ETF (DAVA)	Equity - Australia Strategy	$31.410	-0.82%	-$82	$9,918

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Clover Corporation Limited (CLV) ETFs

3 ETFs hold Clover Corporation Limited (CLV).

ETF	CLV Weight	MER	Yield
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3.05%
Dimensional Australian Value Trust - Active ETF (DAVA)	0%	0.34%	6.6%

View all 3 ETFs

Clover Corporation Limited (CLV) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	1.25¢	100%	20 Oct 2026	19 Nov 2026	-	-	-
Result	1¢	100%	15 Apr 2026	30 Apr 2026	-	-	-
HFResult	1¢	100%	20 Oct 2025	20 Nov 2025	-	-	-

See all dividends from Clover Corporation Limited (CLV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Clover Corporation Limited (CLV) price-sensitive announcements

CLV - Clover 1H FY26 Results Announcement V2

Clover Corporation Limited reported strong financial and operational performance for the f

Clover Corporation Limited (CLV)
24 Mar 2026 | 8:35 AM

CLV - Clover 1H FY26 Investor Presentation

The Clover Corporation 1H FY26 Investor Presentation highlights strong financial performan

Clover Corporation Limited (CLV)
24 Mar 2026 | 8:19 AM

CLV - Clover 1H FY26 Results Announcement

Clover Corporation Limited announced a strong performance for the first half of FY26, with

Clover Corporation Limited (CLV)
24 Mar 2026 | 8:19 AM

CLV - Clover 1H FY26 Report and Accounts

Clover Corporation Limited reported its financial results for the half-year ended January

Clover Corporation Limited (CLV)
24 Mar 2026 | 8:19 AM

Clover Corporation Limited (CLV) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Clover 2026 AGM and Director Nominations	23 Sep 2026 8:58AM	$0.950	$1.080	risen by 13.68%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Clover 2026 Annual Report	23 Sep 2026 8:57AM	$0.950	$1.080	risen by 13.68%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Clover 2026 Results Presentation	23 Sep 2026 8:55AM	$0.950	$1.080	risen by 13.68%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Dividend/Distribution - CLV	23 Sep 2026 8:40AM	$0.950	$1.080	risen by 13.68%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Clover 2026 Appendix 4G	23 Sep 2026 8:31AM	$0.950	$1.080	risen by 13.68%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$180	Clover 2026 Full Year Market Announcement	23 Sep 2026 8:29AM	$0.950	$1.080	risen by 13.68%

CLV Financial Summary

Year to Jul	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026A	$10.46	$6.30	49.10%	12.40	2.30	2.90%	100.0%
2025A	$7.02	$4.20	361.50%	11.10	1.80	3.80%	100.0%
2024A	$1.52	$0.90	-75.50%	83.80	0.80	1.00%	100.0%

CLV Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Clover Corporation Limited (CLV)	$164M	3.6154	0.0000	0.0000	23.3333	0.0000	0.0000	1.79%	0.00%	0.00%

CLV Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.20	17.30	2.31	0.00
Market	0.33	13.80	1.17	0.79
Sector	1.92	13.20	1.61	0.54

CLV Directors

Name	Position	Start Date
Mr Peter J Davey	Chief Executive Officer, Managing Director	16 Dec 2014
Mr Ian David Glasson	Non-Executive Director	1 Feb 2017
Ms Toni Brendish	Non-Executive Director	20 Oct 2020
Dr Simon Green	Non-Executive Director	20 Oct 2020
Ms Fiona Pearse	Non-Executive Director	1 Aug 2025
Mr Rupert Anthony Harrington	Non-Executive Director, Non-Executive Chairman	1 Jul 2015

Clover Corporation Limited (CLV) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
31 Oct 2025	ALLIBON, Andrew	Buy	Indirect Shares	2,447	$0.650	$1,591.000
28 Oct 2025	PEARSE, Fiona	Buy	Indirect Shares	62,996	$0.636	$40,050.000
27 Oct 2025	PEARSE, Fiona	Buy	Indirect Shares	31,000	$0.650	$20,165.000

See all changes in directors' interest & trades for Clover Corporation Limited (CLV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CLV Management

Name	Position
Andrew Allibon	Chief Financial Officer,Company Secretary

CLV Calendar of Events

Date	Event
22 September 2027	Report (Annual)
22 September 2027	Report (Prelim)
23 March 2027	Report (Interim)
19 November 2026	Div Pay Date
17 November 2026	AGM
21 October 2026	Books Close
20 October 2026	Div Ex Date
16 October 2026	Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us